GlassScriptPhysician profile
Stephen Matthew Engstrom
NPI 1750647509
$148,621.57
in general payments reported to CMS, 2019-2025
10 companies · $51K in 2025
The $51K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,088 · 2020: $3,212 · 2021: $1,247 · 2022: $5,172 · 2023: $37K · 2024: $48K · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $109K · Travel and Lodging: $24K · Food and Beverage: $1,385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $109,352.25 |
| Travel and Lodging | $24,165.75 |
| Food and Beverage | $1,385.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $139,737.97 | 2019-2025 | Djo Surgical |
| Insight Medical Systems, INC. | $5,585.00 | 2023-2024 | Arvis |
| Bone Support INC. | $1,250.08 | 2019 | |
| Zimmer Biomet Holdings, INC. | $978.74 | 2019-2025 | Comprehensive Shoulder System |
| Linkbio Corp | $670.32 | 2022 | |
| Medacta USA, INC. | $200.14 | 2019 | |
| Medtronic USA, INC. | $76.18 | 2019 | |
| Heron Therapeutics, INC. | $62.45 | 2025 | Zynrelef |
| Depuy Synthes Sales INC. | $45.43 | 2019 | |
| Orthofix Medical, INC. | $15.26 | 2024 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Engstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.